pyruvaldehyde and 3-deoxyglucose

pyruvaldehyde has been researched along with 3-deoxyglucose in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bretzel, RG; Brownlee, M; Hammes, HP; Lin, J; Schleicher, E1
Bierhaus, A; Häring, HU; Lehmann, R; Nawroth, PP; Schleicher, ED1
Nakaya, I; Nakayama, K; Nakayama, M; Soma, J; Tezuka, Y; Yahata, M1

Reviews

1 review(s) available for pyruvaldehyde and 3-deoxyglucose

ArticleYear
Chemistry and pathobiology of advanced glycation end products.
    Contributions to nephrology, 2001, Issue:131

    Topics: Aging; Deoxyglucose; Diabetes Mellitus; Diabetic Nephropathies; Gene Expression Regulation; Glucose; Glycation End Products, Advanced; Glycoproteins; Glycosylation; Glyoxal; Humans; Kidney Glomerulus; Lipid Peroxidation; NF-kappa B; Oxidative Stress; Pyruvaldehyde; Reactive Oxygen Species

2001

Other Studies

2 other study(ies) available for pyruvaldehyde and 3-deoxyglucose

ArticleYear
Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.
    Diabetologia, 1999, Volume: 42, Issue:5

    Topics: Adult; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Leukocyte Common Antigens; Lysine; Male; Middle Aged; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyruvaldehyde; Risk Factors; T-Lymphocytes

1999
Methylglyoxal as a prognostic factor in patients with chronic kidney disease.
    Nephrology (Carlton, Vic.), 2019, Volume: 24, Issue:9

    Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Deoxyglucose; Diabetic Nephropathies; Disease Progression; Female; Humans; Japan; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyruvaldehyde; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Up-Regulation

2019